50 employees
Catamaran Bio is a biotechnology company that specializes in allogeneic immune cell therapies.
2020
$42M
from 5 investors over 5 rounds
Catamaran Bio raised $42M on November 23, 2020
Investors: Astellas Venture Capital L.L.C., Sofinnova Partners, Lightstone Ventures, SV Life Sciences and Takeda UK Limited